Calligonine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 412239

CAS#: 525-40-6

Description: Calligonine, or Tetrahydroharman is a major alkaloid constituent of the roots of Calligonum minimum and the bark of Elaeagnus angustifolia. When taken internally, it has the effect of substantially lowering blood pressure for an extended period of time, similar to reserpine.


Chemical Structure

img
Calligonine
CAS# 525-40-6

Theoretical Analysis

MedKoo Cat#: 412239
Name: Calligonine
CAS#: 525-40-6
Chemical Formula: C12H14N2
Exact Mass: 186.1157
Molecular Weight: 186.26
Elemental Analysis: C, 77.38; H, 7.58; N, 15.04

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Calligonine; Tetrahydroharman

IUPAC/Chemical Name: 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-1-methyl-, (+-)-

InChi Key: LPIJOZBIVDCQTE-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H14N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-5,8,13-14H,6-7H2,1H3

SMILES Code: CC1NCCC2=C1NC3=C2C=CC=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 186.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Soares ER, da Silva FM, de Almeida RA, de Lima BR, da Silva Filho FA, Barison A, Koolen HH, Pinheiro ML, de Souza AD. Direct infusion ESI-IT-MSn alkaloid profile and isolation of tetrahydroharman and other alkaloids from Bocageopsis pleiosperma maas (Annonaceae). Phytochem Anal. 2015 Sep-Oct;26(5):339-45. doi: 10.1002/pca.2568. Epub 2015 Jun 24. PMID: 26108161.

2: Song H, Liu Y, Liu Y, Wang L, Wang Q. Synthesis and antiviral and fungicidal activity evaluation of β-carboline, dihydro-β-carboline, tetrahydro-β-carboline alkaloids, and their derivatives. J Agric Food Chem. 2014 Feb 5;62(5):1010-8. doi: 10.1021/jf404840x. Epub 2014 Jan 24. PMID: 24460429.

3: Mbaya AW, Ogwiji M. In-vivo and In-vitro activities of medicinal plants on ecto, endo and haemoparasitic infections: a review. Curr Clin Pharmacol. 2014;9(3):271-82. doi: 10.2174/1574884709999140606161757. PMID: 23173971.

4: Fiot J, Sanon S, Azas N, Mahiou V, Jansen O, Angenot L, Balansard G, Ollivier E. Phytochemical and pharmacological study of roots and leaves of Guiera senegalensis J.F. Gmel (Combretaceae). J Ethnopharmacol. 2006 Jun 30;106(2):173-8. doi: 10.1016/j.jep.2005.12.030. Epub 2006 Jan 27. PMID: 16443341.

5: Callaway JC. Fast and slow metabolizers of Hoasca. J Psychoactive Drugs. 2005 Jun;37(2):157-61. doi: 10.1080/02791072.2005.10399797. PMID: 16149329.

6: Ancolio C, Azas N, Mahiou V, Ollivier E, Di Giorgio C, Keita A, Timon-David P, Balansard G. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother Res. 2002 Nov;16(7):646-9. doi: 10.1002/ptr.1025. PMID: 12410545.

7: Azas N, Laurencin N, Delmas F, Di GC, Gasquet M, Laget M, Timon-David P. Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Parasitol Res. 2002 Feb;88(2):165-71. doi: 10.1007/s004360100454. PMID: 11936507.

8: Tsuchiya H, Hayashi T. A possible link between beta -carboline metabolism and infantile autism. Med Hypotheses. 2000 Sep;55(3):215-7. doi: 10.1054/mehy.1999.1046. PMID: 10985911.

9: Callaway JC, Airaksinen MM, Salmela KS, Salaspuro M. Formation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro-beta-carboline) by Helicobacter pylori in the presence of ethanol and tryptamine. Life Sci. 1996;58(21):1817-21. doi: 10.1016/0024-3205(96)00165-8. PMID: 8637407.

10: Kühn-Velten WN. Norharman (beta-carboline) as a potent inhibitory ligand for steroidogenic cytochromes P450 (CYP11 and CYP17). Eur J Pharmacol. 1993 Nov 30;250(1):R1-3. doi: 10.1016/0014-2999(93)90648-2. PMID: 8119304.

11: Benkrief R, Brum-Bousquet M, Tillequin F, Koch M. Alcaloïdes et flavonoïde des parties aériennes de Hammada articulata ssp. scoparia [Alkaloids and flavonoid from aerial parts of Hammada articulata ssp. scoparia]. Ann Pharm Fr. 1990;48(4):219-24. French. PMID: 2080838.

12: Susilo R, Rommelspacher H. Formation of 1-methyl-beta-carbolines in rats from their possible carboxylic acid precursor. Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):566-71. doi: 10.1007/BF00182733. PMID: 3412494.

13: Susilo R, Damm H, Rommelspacher H, Höfle G. Biotransformation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-1-carboxylic acid to harmalan, tetrahydroharman and harman in rats. Neurosci Lett. 1987 Oct 29;81(3):325-30. doi: 10.1016/0304-3940(87)90404-6. PMID: 3431747.

14: Susilo R, Rommelspacher H. Formation of a beta-carboline (1,2,3,4-tetrahydro-1-methyl-beta-carboline-1-carboxylic acid) following intracerebroventricular injection of tryptamine and pyruvic acid. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):70-6. doi: 10.1007/BF00165039. PMID: 3574494.

15: Pentikäinen HT, Airaksinen MM, Tuomisto L, Peura P. Effect of 1-methyl- tetrahydro-beta-carboline on voluntary alcohol intake in rats: lack of increase with fixed alcohol concentrations. Alcohol Alcohol. 1986;21(1):33-9. PMID: 3954828.

16: Rommelspacher H, Brüning G, Susilo R, Nick M, Hill R. Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline). Eur J Pharmacol. 1985 Mar 12;109(3):363-71. doi: 10.1016/0014-2999(85)90397-8. PMID: 2580722.

17: Susilo R, Rommelspacher H. On the mode of formation of beta-carbolines. Prog Clin Biol Res. 1985;183:137-43. PMID: 3901017.

18: Skup M, Oderfeld-Nowak B, Rommelspacher H. In vitro studies on the effect of beta-carbolines on the activities of acetylcholinesterase and choline acetyltransferase and on the muscarinic receptor binding of the rat brain. J Neurochem. 1983 Jul;41(1):62-8. doi: 10.1111/j.1471-4159.1983.tb11814.x. PMID: 6864229.

19: Greiner B, Fähndrich C, Strauss S, Rommelspacher H. Pharmacokinetics of tetrahydronorharmane (tetrahydro-beta-carboline) in rats. Naunyn Schmiedebergs Arch Pharmacol. 1983 Mar;322(2):140-8. doi: 10.1007/BF00512387. PMID: 6866129.

20: Hsu LL, Halaris AE, Freedman DX. Rat brain aryl acylamidase: further characterization of multiple forms. Int J Biochem. 1982;14(7):581-4. doi: 10.1016/0020-711x(82)90040-4. PMID: 7106357.